This inventor holds 1 USPTO granted patent. Top assignees: Mahidol University, Osaka University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 9 
1 out of 1,044 
Years Active: 2023
Title: Natthanej Luplertlop: Innovator in Monoclonal Antibodies
Introduction
Natthanej Luplertlop is a prominent inventor based in Bangkok, Thailand. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on combating viral infections, showcasing his dedication to advancing medical science.
Latest Patents
Natthanej Luplertlop holds a patent for "Broad-spectrum monoclonal antibodies against chikungunya virus E1 structural protein." This invention provides a new antibody targeting various types of Chikungunya virus, including ECSA, WA, and Asian types. The antibody comprises a heavy chain variable region and a light chain variable region, which are crucial for its functionality in neutralizing the virus.
Career Highlights
Throughout his career, Luplertlop has worked with esteemed institutions such as Osaka University and Mahidol University. His research has contributed to the understanding and treatment of viral diseases, particularly those affecting tropical regions.
Collaborations
He has collaborated with notable colleagues, including Tatsuo Shioda and Emi Nakayama. These partnerships have enhanced his research efforts and expanded the impact of his innovations in the scientific community.
Conclusion
Natthanej Luplertlop's work in developing monoclonal antibodies represents a significant advancement in the fight against viral infections. His contributions to biotechnology continue to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile